Sobrera, Recipharm Collaborate to Advance Alcohol Use Disorder Treatment
Sobrera Pharma, and Recipharm have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for... Read More
Centaur Pharma launches WOXheal to treat diabetic foot ulcers
Centaur Pharmaceuticals announced the launch of a new chemical entity (NCE) – WOXheal for the treatment of diabetic foot ulcers, and it... Read More
FSD Pharma gets US FDA nod to begin phase 2 study of FSD201 to treat COVID-19
FSD Pharma announced that the US Food and Drug Administration (FDA) has authorized the initiation of a phase 2 study for the... Read More
AbbVie’s Elezanumab receives US FDA orphan drug and fast track designations
Posted on30 Sep 2020
Comments0
AbbVie announced that the US Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an... Read More
USFDA granted expanded access to investigational ERK inhibitor ulixertinib
The US Food and Drug Administration has granted expanded access to BioMed Valley Discoveries’ investigational ERK inhibitor ulixertinib for patients with cancers... Read More
Case Study – Strategic Insight on Gilead and Immunomedics $21 Billion Deal
Posted on15 Sep 2020
Comments0
Gilead Sciences Inc. agreed to acquire Immunomedics Inc. for about $21 billion, a substantial premium for the maker of a promising breast-cancer... Read More
Insight on USFDA approval of pralsetinib to treat non-small lung cancer
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S.... Read More
What is hybrid clinical trial?
Posted on15 Sep 2020
Comments0
A hybrid trial is a type of clinical trial which includes both traditional and pragmatic clinical trial elements. Randomized controlled trials are generally... Read More
Strides Pharma to acquire 54% stake in SteriScience
Posted on15 Sep 2020
Comments0
Strides Pharma Science will invest Rs 135 crore over the next 24 months to acquire around 54 percent stake in SteriScience Pharma... Read More
Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine
Aurobindo Pharma is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a... Read More